TBC1D24 genotype–phenotype correlation

Objective: To evaluate the phenotypic spectrum associated with mutations in TBC1D24. Methods: We acquired new clinical, EEG, and neuroimaging data of 11 previously unreported and 37 published patients. TBC1D24 mutations, identified through various sequencing methods, can be found online (http://lovd.nl/TBC1D24). Results: Forty-eight patients were included (28 men, 20 women, average age 21 years) from 30 independent families. Eighteen patients (38%) had myoclonic epilepsies. The other patients carried diagnoses of focal (25%), multifocal (2%), generalized (4%), and unclassified epilepsy (6%), and early-onset epileptic encephalopathy (25%). Most patients had drug-resistant epilepsy. We detail EEG, neuroimaging, developmental, and cognitive features, treatment responsiveness, and physical examination. In silico evaluation revealed 7 different highly conserved motifs, with the most common pathogenic mutation located in the first. Neuronal outgrowth assays showed that some TBC1D24 mutations, associated with the most severe TBC1D24-associated disorders, are not necessarily the most disruptive to this gene function. Conclusions: TBC1D24-related epilepsy syndromes show marked phenotypic pleiotropy, with multisystem involvement and severity spectrum ranging from isolated deafness (not studied here), benign myoclonic epilepsy restricted to childhood with complete seizure control and normal intellect, to early-onset epileptic encephalopathy with severe developmental delay and early death. There is no distinct correlation with mutation type or location yet, but patterns are emerging. Given the phenotypic breadth observed, TBC1D24 mutation screening is indicated in a wide variety of epilepsies. A TBC1D24 consortium was formed to develop further research on this gene and its associated phenotypes.

[1]  Majida Charif,et al.  Recessive TBC1D24 Mutations Are Frequent in Moroccan Non-Syndromic Hearing Loss Pedigrees , 2015, PloS one.

[2]  D. Rodriguez,et al.  A Novel Homozygous TBC1D24 Mutation Causing Multifocal Myoclonus With Cerebellar Involvement , 2015, Movement disorders : official journal of the Movement Disorder Society.

[3]  J. Holder,et al.  TBC1D24: A Novel Mutation Causing Intellectual Disability and Epilepsy (P6.271) , 2015 .

[4]  K. Davies,et al.  Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis , 2015, Brain : a journal of neurology.

[5]  D. Ville,et al.  Homozygous TBC1D24 mutation in two siblings with familial infantile myoclonic epilepsy (FIME) and moderate intellectual disability , 2015, Epilepsy Research.

[6]  D. Neubauer,et al.  Early-onset epileptic encephalopathy with hearing loss in two siblings with TBC1D24 recessive mutations. , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[7]  M. Daly,et al.  A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy , 2014, Nature Genetics.

[8]  P. Verstreken,et al.  Reduced synaptic vesicle protein degradation at lysosomes curbs TBC1D24/sky-induced neurodegeneration , 2014, The Journal of cell biology.

[9]  R. Hennekam,et al.  DOORS syndrome: Phenotype, genotype and comparison with Coffin‐Siris syndrome , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[10]  D. Kolbe,et al.  TBC1D24 Mutation Causes Autosomal‐Dominant Nonsyndromic Hearing Loss , 2014, Human mutation.

[11]  Tao Yang,et al.  A Dominant Mutation in the Stereocilia‐Expressing Gene TBC1D24 is a Probable Cause for Nonsyndromic Hearing Impairment , 2014, Human mutation.

[12]  S. Pappatà,et al.  Parkinsonism may be part of the symptom complex of DOOR syndrome. , 2014, Parkinsonism & related disorders.

[13]  A. Represa,et al.  TBC1D24 regulates neuronal migration and maturation through modulation of the ARF6-dependent pathway , 2014, Proceedings of the National Academy of Sciences.

[14]  J. Shendure,et al.  Mutations in TBC1D24, a gene associated with epilepsy, also cause nonsyndromic deafness DFNB86. , 2014, American journal of human genetics.

[15]  Jonathan E. Dickerson,et al.  The genetic basis of DOORS syndrome: an exome-sequencing study , 2014, The Lancet Neurology.

[16]  J. Gécz,et al.  TBC1D24 mutation associated with focal epilepsy, cognitive impairment and a distinctive cerebro-cerebellar malformation , 2013, Epilepsy Research.

[17]  F. Benfenati,et al.  Novel Compound Heterozygous Mutations in TBC1D24 Cause Familial Malignant Migrating Partial Seizures of Infancy , 2013, Human mutation.

[18]  A. Tolun,et al.  TBC1D24 truncating mutation resulting in severe neurodegeneration , 2013, Journal of Medical Genetics.

[19]  Chunlei Wu,et al.  BioGPS and MyGene.info: organizing online, gene-centric information , 2012, Nucleic Acids Res..

[20]  V. Baert,et al.  ARF6-mediated endosomal transport of Telencephalin affects dendritic filopodia-to-spine maturation , 2012, The EMBO journal.

[21]  P. McPherson,et al.  Connecdenn 3/DENND1C binds actin linking Rab35 activation to the actin cytoskeleton , 2012, Molecular biology of the cell.

[22]  K. Murphy,et al.  Structural/functional analysis of the human OXR1 protein: identification of exon 8 as the anti-oxidant encoding function , 2012, BMC Molecular Biology.

[23]  K. Davies,et al.  Oxr1 Is Essential for Protection against Oxidative Stress-Induced Neurodegeneration , 2011, PLoS genetics.

[24]  Mitsunori Fukuda,et al.  TBC proteins: GAPs for mammalian small GTPase Rab? , 2011, Bioscience reports.

[25]  P. Verstreken,et al.  Loss of Skywalker Reveals Synaptic Endosomes as Sorting Stations for Synaptic Vesicle Proteins , 2011, Cell.

[26]  A. Tolun,et al.  Early-Onset Progressive Myoclonic Epilepsy With Dystonia Mapping to 16pter-p13.3 , 2010, Journal of neurogenetics.

[27]  F. Benfenati,et al.  TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. , 2010, American journal of human genetics.

[28]  J. Gécz,et al.  A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. , 2010, American journal of human genetics.

[29]  G. Köhr,et al.  AMPA Receptor Signaling through BRAG2 and Arf6 Critical for Long-Term Synaptic Depression , 2010, Neuron.

[30]  G. Mathern,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[31]  Mikael Bodén,et al.  MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..

[32]  S. Saygi,et al.  Eye closure sensitivity and epileptic syndromes: A retrospective study of 26 adult cases , 2007, Seizure.

[33]  Crislyn D'Souza-Schorey,et al.  ARF proteins: roles in membrane traffic and beyond , 2006, Nature Reviews Molecular Cell Biology.

[34]  M. Roth,et al.  ARNO and ARF6 regulate axonal elongation and branching through downstream activation of phosphatidylinositol 4-phosphate 5-kinase alpha. , 2003, Molecular biology of the cell.

[35]  F. Zara,et al.  Familial Infantile Myoclonic Epilepsy: Clinical Features in a Large Kindred with Autosomal Recessive Inheritance , 2001, Epilepsia.

[36]  J. Rosenfeld,et al.  TBC 1 D 24 genotype – phenotype correlation Epilepsies and other neurologic features , 2022 .